LifeMD, Inc.
LFMD
$4.29
-$0.385-8.24%
| Weiss Ratings | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.81 | |||
| Price History | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -14.64% | |||
| 30-Day Total Return | -16.47% | |||
| 60-Day Total Return | -27.37% | |||
| 90-Day Total Return | -0.12% | |||
| Year to Date Total Return | -18.07% | |||
| 1-Year Total Return | -46.44% | |||
| 2-Year Total Return | 140.73% | |||
| 3-Year Total Return | 31.44% | |||
| 5-Year Total Return | 614.17% | |||
| 52-Week High % Change | -63.74% | |||
| 52-Week Low % Change | 17.04% | |||
| Price | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $12.88 | |||
| 52-Week Low Price | $3.99 | |||
| 52-Week Low Price (Date) | Oct 30, 2024 | |||
| 52-Week High Price (Date) | May 07, 2024 | |||
| Valuation | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 202.27M | |||
| Enterprise Value | 191.59M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.65 | |||
| Earnings Per Share Growth | -34.25% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.02 | |||
| Price/Book (Q) | -25.28 | |||
| Enterprise Value/Revenue (TTM) | 0.99 | |||
| Price | $4.29 | |||
| Enterprise Value/EBITDA (TTM) | -10.66 | |||
| Enterprise Value/EBIT | -9.91 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 42.02M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -13.80% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 866 351 5907 | |||
| Address | 236 Fifth Avenue New York, NY 10001 | |||
| Website | lifemd.com | |||
| Country | United States | |||
| Year Founded | 1994 | |||
| Profitability | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -10.01% | |||
| Profit Margin | -11.65% | |||
| Management Effectiveness | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -21.34% | |||
| Return on Equity | -- | |||
| Income Statement | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 193.06M | |||
| Total Revenue (TTM) | 193.06M | |||
| Revenue Per Share | $4.59 | |||
| Gross Profit (TTM) | 173.06M | |||
| EBITDA (TTM) | -17.98M | |||
| EBIT (TTM) | -19.33M | |||
| Net Income (TTM) | -22.51M | |||
| Net Income Avl. to Common (TTM) | -25.61M | |||
| Total Revenue Growth (Q YOY) | 38.27% | |||
| Earnings Growth (Q YOY) | -3.67% | |||
| EPS Diluted (TTM) | -0.65 | |||
| EPS Diluted Growth (Q YOY) | 29.74% | |||
| Balance Sheet | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 37.59M | |||
| Cash Per Share (Q) | $0.89 | |||
| Total Current Assets (Q) | 48.66M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -5.96M | |||
| Current Ratio (Q) | 0.825 | |||
| Book Value Per Share (Q) | -$0.18 | |||
| Total Assets (Q) | 72.56M | |||
| Total Current Liabilities (Q) | 58.95M | |||
| Total Debt (Q) | 25.14M | |||
| Total Liabilities (Q) | 78.52M | |||
| Total Common Equity (Q) | -7.72M | |||
| Cash Flow | LFMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -11.03M | |||
| Cash from Financing (TTM) | 11.67M | |||
| Net Change in Cash (TTM) | 22.30M | |||
| Levered Free Cash Flow (TTM) | 18.02M | |||
| Cash from Operations (TTM) | 21.66M | |||
